Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan Dose Response in Hypertensive Children 1-5 Years
NCT01617681Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2012
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of valsartan in hypertension (HTN), sponsored by Novartis. Started Nov 2012; status: completed.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01617681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01617681.